KIORA PHARMACEUTICALS, INC. Proceeds from Warrant Exercises
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Warrant Exercises of $170 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for the quarter ending 2026-03-31 was $170.00.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for the quarter ending 2025-12-31 was $296.00.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for the quarter ending 2025-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for fiscal 2025 was $265.65K, a 84.27% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for fiscal 2024 was $1.69M, a 450.13% increase from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for fiscal 2023 was $307.08K, a 40.95% decline from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. proceeds from warrant exercises for fiscal 2022 was $520.00K, a 939.98% increase from fiscal 2021.
| Period end | Proceeds from Warrant Exercises 1 month | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $170.00 10-Q · filed 2026-08-07 | $466.00 derived: sum of 3 quarters · filed 2026-08-07 | $466.00 derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $170.00 10-Q · filed 2026-05-08 | $466.00 derived: sum of 2 quarters · filed 2026-05-08 | $466.00 derived: sum of 3 quarters · filed 2026-05-08 | $265.82K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $296.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $296.00 derived: sum of 2 quarters · filed 2026-03-25 | $265.65K derived: sum of 3 quarters · filed 2026-08-07 | $265.65K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $265.36K derived: sum of 2 quarters · filed 2026-08-07 | $265.36K 10-Q · filed 2025-11-07 | $265.36K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $265.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $265.36K 10-Q · filed 2026-08-07 | $265.36K derived: sum of 3 quarters · filed 2026-08-07 | $265.36K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $250.52K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $250.52K derived: sum of 3 quarters · filed 2026-03-25 | $1.69M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $250.52K derived: sum of 2 quarters · filed 2025-11-07 | $1.69M 10-Q · filed 2025-11-07 | $1.70M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $250.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.69M 10-Q · filed 2025-08-08 | $1.70M derived: sum of 3 quarters · filed 2025-08-08 | $1.70M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $1.44M 10-Q · filed 2025-05-09 | $1.45M derived: sum of 2 quarters · filed 2025-05-09 | $1.45M derived: sum of 3 quarters · filed 2025-05-09 | $1.45M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $8.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $8.58K derived: sum of 2 quarters · filed 2025-03-25 | $8.58K derived: sum of 3 quarters · filed 2025-03-25 | $307.08K 10-K · filed 2025-03-25 | |
| 2023-11-30 | $8.60K 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $298.50K 10-Q · filed 2024-11-08 | $818.50K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $298.50K 10-Q · filed 2024-08-09 | $818.50K derived: sum of 3 quarters · filed 2024-08-09 | $818.50K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $298.50K 10-Q · filed 2024-05-10 | $818.50K derived: sum of 2 quarters · filed 2024-05-10 | $818.50K derived: sum of 3 quarters · filed 2024-05-10 | $818.50K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $520.00K derived: sum of 2 quarters · filed 2024-03-25 | $520.00K derived: sum of 3 quarters · filed 2024-03-25 | $520.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | $0.00 derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $0.00 derived: sum of 3 quarters · filed 2023-05-09 | $0.00 derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $50.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $50.00K 10-Q · filed 2022-11-09 | $268.00K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $50.00K 10-Q · filed 2022-08-12 | $268.00K derived: sum of 3 quarters · filed 2022-08-12 | $268.00K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $50.00K 10-Q · filed 2022-07-08 | $268.00K derived: sum of 2 quarters · filed 2022-07-08 | $268.00K derived: sum of 3 quarters · filed 2022-07-08 | ||
| 2020-12-31 | $218.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | $218.00K derived: sum of 2 quarters · filed 2022-07-07 | $218.00K 10-K/A · filed 2022-07-07 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | ||||
| 2019-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.12M derived: sum of 2 quarters · filed 2021-03-25 | $2.15M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $32.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $32.00K 10-Q · filed 2020-08-06 | ||||
| 2018-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $451.60K derived: sum of 2 quarters · filed 2020-03-04 | $1.21M 10-K · filed 2020-03-04 | ||
| 2018-09-30 | $339.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.09M 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | $754.23K 10-Q · filed 2019-08-08 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |